{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:01:58Z","timestamp":1793106118627,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Institute of Hospital Administration","award":["YLZLXZ23G019"],"award-info":[{"award-number":["YLZLXZ23G019"]}]},{"name":"the National Institute of Hospital Administration","award":["YLZLXZ23G019"],"award-info":[{"award-number":["YLZLXZ23G019"]}]},{"name":"the National Institute of Hospital Administration","award":["YLZLXZ23G019"],"award-info":[{"award-number":["YLZLXZ23G019"]}]},{"name":"the \u201c3456\u201d Cultivation Program For Junior Talents of Nanjing Stomatological Hospital, Medical School of Nanjing University","award":["0222N404"],"award-info":[{"award-number":["0222N404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02720-6","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:00:49Z","timestamp":1747900849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Quality of life and symptom burden among hematologic malignancy patients undergoing CAR-T therapy: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Hongyuan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"1","key":"2720_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ejh.14335","volume":"114","author":"F Morabito","year":"2025","unstructured":"Morabito, F., Martino, E. A. & Nizzoli, M. E. Comparative analysis of bispecific antibodies and CAR T-Cell therapy in follicular lymphoma. Eur. J. Haematol. 114(1), 4\u201316. https:\/\/doi.org\/10.1111\/ejh.14335 (2025).","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"2720_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.medj.2024.03.016","volume":"5","author":"J Shu","year":"2024","unstructured":"Shu, J., Xie, W. & Chen, Z. The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases. Med 5(6), 495\u2013529. https:\/\/doi.org\/10.1016\/j.medj.2024.03.016 (2024).","journal-title":"Med. (New York NY)"},{"issue":"9","key":"2720_CR3","doi-asserted-by":"publisher","first-page":"e937","DOI":"10.1097\/hs9.0000000000000937","volume":"7","author":"J Vanhooren","year":"2023","unstructured":"Vanhooren, J., Dobbelaere, R. & Derpoorter, C. CAR-T in the treatment of acute myeloid leukemia: Barriers and how to overcome them. HemaSphere 7(9), e937. https:\/\/doi.org\/10.1097\/hs9.0000000000000937 (2023).","journal-title":"HemaSphere"},{"key":"2720_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2455488","author":"PJ O'Shea","year":"2025","unstructured":"O\u2019Shea, P. J., Johnson, P. C. & El-Jawahri, A. Unmet needs and lived experience of patients receiving CAR T-cell therapy. Leuk. Lymphoma. https:\/\/doi.org\/10.1080\/10428194.2025.2455488 (2025).","journal-title":"Leuk. Lymphoma"},{"key":"2720_CR5","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/bcj.2015.29","volume":"5","author":"P Allart-Vorelli","year":"2015","unstructured":"Allart-Vorelli, P., Porro, B. & Baguet, F. Haematological cancer and quality of life: A systematic literature review. Blood Cancer J. 5, e305. https:\/\/doi.org\/10.1038\/bcj.2015.29 (2015).","journal-title":"Blood cancer J."},{"issue":"3","key":"2720_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/ejh.13104","volume":"101","author":"P Esser","year":"2018","unstructured":"Esser, P., Kuba, K. & Mehnert, A. Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantation. Eur. J. Haematol. 101(3), 340\u2013348. https:\/\/doi.org\/10.1111\/ejh.13104 (2018).","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"2720_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.0902-4441.2003.00195.x","volume":"72","author":"N Gulbrandsen","year":"2004","unstructured":"Gulbrandsen, N., Hjermstad, M. J. & Wisloff, F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur. J. Haematol. 72(3), 172\u2013180. https:\/\/doi.org\/10.1046\/j.0902-4441.2003.00195.x (2004).","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"2720_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen, A. T., Tholstrup, D. & Petersen, M. A. Health related quality of life in a nationally representative sample of haematological patients. Eur. J. Haematol. 83(2), 139\u2013148. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01250.x (2009).","journal-title":"Eur. J. Haematol."},{"issue":"2\u20133","key":"2720_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10376178.2019.1623699","volume":"55","author":"HY Kang","year":"2019","unstructured":"Kang, H. Y. & Choi, E. Y. Factors influencing quality of life in patients with multiple myeloma. Contemp. Nurse 55(2\u20133), 109\u2013121. https:\/\/doi.org\/10.1080\/10376178.2019.1623699 (2019).","journal-title":"Contemp. Nurse"},{"issue":"11","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1089\/jpm.2017.0069","volume":"20","author":"MJ Cheng","year":"2017","unstructured":"Cheng, M. J., Smith, B. D. & Hourigan, C. S. A single center survey of health-related quality of life among acute myeloid leukemia survivors in first complete remission. J. Palliat. Med. 20(11), 1267\u20131273. https:\/\/doi.org\/10.1089\/jpm.2017.0069 (2017).","journal-title":"J. Palliat. Med."},{"issue":"1","key":"2720_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/caac.21702","volume":"72","author":"A Shimabukuro-Vornhagen","year":"2022","unstructured":"Shimabukuro-Vornhagen, A., B\u00f6ll, B. & Schellongowski, P. Critical care management of chimeric antigen receptor T-cell therapy recipients. Cancer J. Clin. 72(1), 78\u201393. https:\/\/doi.org\/10.3322\/caac.21702 (2022).","journal-title":"Cancer J. Clin."},{"issue":"3","key":"2720_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3322\/caac.21771","volume":"73","author":"RH Parikh","year":"2023","unstructured":"Parikh, R. H. & Lonial, S. Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice. Cancer J. Clin. 73(3), 275\u2013285. https:\/\/doi.org\/10.3322\/caac.21771 (2023).","journal-title":"Cancer J. Clin."},{"issue":"24","key":"2720_CR13","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMc2213985","volume":"387","author":"A Quint\u00e1s-Cardama","year":"2022","unstructured":"Quint\u00e1s-Cardama, A. GPRC5D-targeted CAR T cells for Myeloma. N. Engl. J. Med. 387(24), 2295\u20132296. https:\/\/doi.org\/10.1056\/NEJMc2213985 (2022).","journal-title":"N. Engl. J. Med."},{"issue":"10480","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/s0140-6736(25)00039-x","volume":"405","author":"DJ Baker","year":"2025","unstructured":"Baker, D. J., Levine, B. L. & June, C. H. Assessing the oncogenic risk: The long-term safety of autologous chimeric antigen receptor T cells. Lancet 405(10480), 751\u2013754. https:\/\/doi.org\/10.1016\/s0140-6736(25)00039-x (2025).","journal-title":"Lancet (London England)"},{"issue":"7","key":"2720_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa2116133","volume":"386","author":"FL Locke","year":"2022","unstructured":"Locke, F. L., Miklos, D. B. & Jacobson, C. A. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma. N. Engl. J. Med. 386(7), 640\u2013654. https:\/\/doi.org\/10.1056\/NEJMoa2116133 (2022).","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"2720_CR16","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1200\/jco.21.01676","volume":"40","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Cao, J. & Gu, W. Long-term follow-up of combination of B-Cell maturation antigen and CD19 chimeric antigen receptor T cells in multiple Myeloma. J. Clin. Oncol. 40(20), 2246\u20132256. https:\/\/doi.org\/10.1200\/jco.21.01676 (2022).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"issue":"5","key":"2720_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa1709919","volume":"378","author":"JH Park","year":"2018","unstructured":"Park, J. H., Rivi\u00e8re, I. & Gonen, M. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N. Engl. J. Med. 378(5), 449\u2013459. https:\/\/doi.org\/10.1056\/NEJMoa1709919 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2720_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00174-0","author":"R Cheng","year":"2021","unstructured":"Cheng, R., Scippa, K. & Locke, F. L. Patient perspectives on health-related quality of life in diffuse large B-cell lymphoma treated with car T-Cell therapy: A qualitative study. Oncol. Ther. https:\/\/doi.org\/10.1007\/s40487-021-00174-0 (2021).","journal-title":"Oncol. therapy"},{"key":"2720_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jad.2021.02.041","volume":"286","author":"H Dai","year":"2021","unstructured":"Dai, H., Xu, S. & Han, J. Prevalence and factors associated with anxiety and depressive symptoms among patients hospitalized with hematological malignancies after chimeric antigen receptor T-cell (CAR-T) therapy: A cross-sectional study. J. Affect. Disord. 286, 33\u201339. https:\/\/doi.org\/10.1016\/j.jad.2021.02.041 (2021).","journal-title":"J. Affect. Disord."},{"issue":"4","key":"2720_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","volume":"34","author":"N Shah","year":"2020","unstructured":"Shah, N., Chari, A. & Scott, E. B-cell maturation antigen (BCMA) in multiple myeloma: Rationale for targeting and current therapeutic approaches. Leukemia 34(4), 985\u20131005. https:\/\/doi.org\/10.1038\/s41375-020-0734-z (2020).","journal-title":"Leukemia"},{"issue":"10","key":"2720_CR21","first-page":"1155","volume":"69","author":"JR Johnson","year":"1985","unstructured":"Johnson, J. R. & Temple, R. Food and drug administration requirements for approval of new anticancer drugs. Cancer Treat. Rep. 69(10), 1155\u20131159 (1985).","journal-title":"Cancer Treat. Rep."},{"issue":"10","key":"2720_CR22","doi-asserted-by":"publisher","first-page":"e0205729","DOI":"10.1371\/journal.pone.0205729","volume":"13","author":"X Wu","year":"2018","unstructured":"Wu, X., Li, Z. & Cao, J. The association between major complications of immobility during hospitalization and quality of life among bedridden patients: A 3 month prospective multi-center study. PloS One 13(10), e0205729. https:\/\/doi.org\/10.1371\/journal.pone.0205729 (2018).","journal-title":"PloS One"},{"issue":"4","key":"2720_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.soc.2018.05.008","volume":"27","author":"A Sitlinger","year":"2018","unstructured":"Sitlinger, A. & Zafar, S. Y. Health-Related quality of life: The impact on morbidity and Mortality. Surg. Oncol. Clin. N. Am. 27(4), 675\u2013684. https:\/\/doi.org\/10.1016\/j.soc.2018.05.008 (2018).","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"5","key":"2720_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-0609.2008.01126.x","volume":"81","author":"K Strasser-Weippl","year":"2008","unstructured":"Strasser-Weippl, K. & Ludwig, H. Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. Eur. J. Haematol. 81(5), 374\u2013379. https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01126.x (2008).","journal-title":"Eur. J. Haematol."},{"issue":"7196","key":"2720_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1136\/bmj.318.7196.1460","volume":"318","author":"H Hemingway","year":"1999","unstructured":"Hemingway, H. & Marmot, M. Evidence based cardiology: Psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318(7196), 1460\u20131467. https:\/\/doi.org\/10.1136\/bmj.318.7196.1460 (1999).","journal-title":"BMJ (Clinical Res. ed)"},{"issue":"1","key":"2720_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s43856-022-00116-5","volume":"2","author":"JM Knight","year":"2022","unstructured":"Knight, J. M., Szabo, A. & Arapi, I. Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy. Commun. Med. 2(1), 49. https:\/\/doi.org\/10.1038\/s43856-022-00116-5 (2022).","journal-title":"Commun. Med."},{"issue":"4","key":"2720_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/bloodadvances.2019001026","volume":"4","author":"RT Maziarz","year":"2020","unstructured":"Maziarz, R. T., Waller, E. K. & Jaeger, U. Patient-reported long-term quality of life after tisagenlecleucel in relapsed\/refractory diffuse large B-cell lymphoma. Blood Adv. 4(4), 629\u2013637. https:\/\/doi.org\/10.1182\/bloodadvances.2019001026 (2020).","journal-title":"Blood Adv."},{"key":"2720_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30493-0","author":"TW Laetsch","year":"2019","unstructured":"Laetsch, T. W., Myers, G. D. & Baruchel, A. Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: A global, single-arm, phase 2 trial. Lancet Oncol. https:\/\/doi.org\/10.1016\/s1470-2045(19)30493-0 (2019).","journal-title":"Lancet Oncol."},{"key":"2720_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30641-2","author":"F Efficace","year":"2019","unstructured":"Efficace, F. & Vignetti, M. Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignancies. Lancet Oncol. https:\/\/doi.org\/10.1016\/s1470-2045(19)30641-2 (2019).","journal-title":"Lancet Oncol."},{"issue":"3","key":"2720_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/jco.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella, D. F., Tulsky, D. S. & Gray, G. The functional assessment of Cancer therapy scale: Development and validation of the general measure. J. Clin. Oncol. 11(3), 570\u2013579. https:\/\/doi.org\/10.1200\/jco.1993.11.3.570 (1993).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"2720_CR31","first-page":"665","volume":"88","author":"K Zhang","year":"2008","unstructured":"Zhang, K., Gong, K. & Zhou, L. Q. Quality of life among patients with advanced prostate cancer: A survey using functional assessment of cancer therapy-prostate in China. Zhonghua Yi Xue Za Zhi 88(10), 665\u2013668 (2008).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"2720_CR32","first-page":"225","volume":"26","author":"CH Wan","year":"2007","unstructured":"Wan, C. H., Meng, Q. & Yang, Z. Development of the general module of the system of quality of life instruments for cancer patients: Reliability and validity analysis. Ai Zheng = Aizheng = Chinese Journal of Cancer 26(3), 225\u2013229 (2007).","journal-title":"Ai zheng = Aizheng = Chin. J. cancer"},{"key":"2720_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju244","author":"E Basch","year":"2014","unstructured":"Basch, E., Reeve, B. B. & Mitchell, S. A. Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J. Natl. Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju244 (2014).","journal-title":"J. Natl Cancer Inst."},{"issue":"10","key":"2720_CR34","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/s2352-3026(19)30115-2","volume":"6","author":"Z Yan","year":"2019","unstructured":"Yan, Z., Cao, J. & Cheng, H. A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial. Lancet Haematol. 6(10), e521\u2013e529. https:\/\/doi.org\/10.1016\/s2352-3026(19)30115-2 (2019).","journal-title":"Lancet Haematol."},{"key":"2720_CR35","doi-asserted-by":"publisher","unstructured":"Lee, D. W., Santomasso, B. D. & Locke, F. L. et.al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol. Blood Marrow Transpl. 25(4), 625\u2013638. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758 (2019).","DOI":"10.1016\/j.bbmt.2018.12.758"},{"issue":"2","key":"2720_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/0163278705275341","volume":"28","author":"PS Brucker","year":"2005","unstructured":"Brucker, P. S., Yost, K. & Cashy, J. General population and cancer patient norms for the functional assessment of Cancer Therapy-General (FACT-G). Eval. Health Prof. 28(2), 192\u2013211. https:\/\/doi.org\/10.1177\/0163278705275341 (2005).","journal-title":"Eval. Health Prof."},{"issue":"12","key":"2720_CR37","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/s1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V., Dimopoulos, M. A. & Palumbo, A. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15(12), e538\u2013548. https:\/\/doi.org\/10.1016\/s1470-2045(14)70442-5 (2014).","journal-title":"Lancet Oncol."},{"issue":"11","key":"2720_CR38","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/jco.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister, T. A., Crowther, D. & Sutcliffe, S. B. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J. Clin. Oncol. 7(11), 1630\u20131636. https:\/\/doi.org\/10.1200\/jco.1989.7.11.1630 (1989).","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"2720_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower, J. E. Cancer-related fatigue\u2013mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 11(10), 597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127 (2014).","journal-title":"Nat. Reviews Clin. Oncol."},{"key":"2720_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34980","author":"AE Heffernan","year":"2023","unstructured":"Heffernan, A. E., Wu, Y. & Benz, L. S. Quality of life after surgery for lower grade gliomas. Cancer. https:\/\/doi.org\/10.1002\/cncr.34980 (2023).","journal-title":"Cancer"},{"issue":"8 Suppl","key":"2720_CR41","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.27475","volume":"118","author":"AM Berger","year":"2012","unstructured":"Berger, A. M., Gerber, L. H. & Mayer, D. K. Cancer-related fatigue: Implications for breast cancer survivors. Cancer 118(8 Suppl), 2261\u20132269. https:\/\/doi.org\/10.1002\/cncr.27475 (2012).","journal-title":"Cancer"},{"key":"2720_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/lctt.S85334","volume":"7","author":"S Carnio","year":"2016","unstructured":"Carnio, S., Di Stefano, R. F. & Novello, S. Fatigue in lung cancer patients: Symptom burden and management of challenges. Lung Cancer 7, 73\u201382. https:\/\/doi.org\/10.2147\/lctt.S85334 (2016).","journal-title":"Lung Cancer (Auckland NZ)"},{"issue":"8","key":"2720_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.6004\/jnccn.2010.0067","volume":"8","author":"AM Berger","year":"2010","unstructured":"Berger, A. M., Abernethy, A. P. & Atkinson, A. NCCN clinical practice guidelines Cancer-related fatigue. J. Natl. Compr. Cancer Netw. JNCCN 8(8), 904\u2013931. https:\/\/doi.org\/10.6004\/jnccn.2010.0067 (2010).","journal-title":"J. Natl. Compr. Cancer Network: JNCCN"},{"issue":"2","key":"2720_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.17925\/ohr.2012.08.2.81","volume":"8","author":"KM Mustian","year":"2012","unstructured":"Mustian, K. M., Sprod, L. K. & Janelsins, M. Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: A review. Oncol. Hematol. Rev. 8(2), 81\u201388. https:\/\/doi.org\/10.17925\/ohr.2012.08.2.81 (2012).","journal-title":"Oncol. Hematol. Rev."},{"key":"2720_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgm005","author":"CS Cleeland","year":"2007","unstructured":"Cleeland, C. S. Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. J. Natl. Cancer Inst. Monogr.. https:\/\/doi.org\/10.1093\/jncimonographs\/lgm005 (2007).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"24","key":"2720_CR46","first-page":"4205","volume":"33","author":"QP Pang","year":"2019","unstructured":"Pang, Q. P., Ji, Y. B. & Xu, C. P. Correlation among symptom clusters, inflammatory cytokine and quality of life among cancer patients based on cluster analysis. Chin. Nurs. Res. 33(24), 4205\u20134210 (2019).","journal-title":"Chin. Nurs. Res."},{"issue":"5","key":"2720_CR47","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/jcem.83.5.4795","volume":"83","author":"E Sp\u00e4th-Schwalbe","year":"1998","unstructured":"Sp\u00e4th-Schwalbe, E., Hansen, K. & Schmidt, F. Acute effects of Recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 83(5), 1573\u20131579. https:\/\/doi.org\/10.1210\/jcem.83.5.4795 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2720_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1099800414550394","volume":"17","author":"SH Doong","year":"2015","unstructured":"Doong, S. H., Dhruva, A. & Dunn, L. B. Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol. Res. Nurs. 17(3), 237\u2013247. https:\/\/doi.org\/10.1177\/1099800414550394 (2015).","journal-title":"Biol. Res. Nurs."},{"issue":"224","key":"2720_CR49","doi-asserted-by":"publisher","first-page":"224ra225","DOI":"10.1126\/scitranslmed.3008226","volume":"6","author":"ML Davila","year":"2014","unstructured":"Davila, M. L., Riviere, I. & Wang, X. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl. Med. 6(224), 224ra225. https:\/\/doi.org\/10.1126\/scitranslmed.3008226 (2014).","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"2720_CR50","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jgo.2018.02.006","volume":"9","author":"KP Loh","year":"2018","unstructured":"Loh, K. P., Zittel, J. & Kadambi, S. Elucidating the associations between sleep disturbance and depression, fatigue, and pain in older adults with cancer. J. Geriatric Oncol. 9(5), 464\u2013468. https:\/\/doi.org\/10.1016\/j.jgo.2018.02.006 (2018).","journal-title":"J. Geriatric Oncol."},{"issue":"8","key":"2720_CR51","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1182\/bloodadvances.2020003503","volume":"5","author":"DL Patrick","year":"2021","unstructured":"Patrick, D. L., Powers, A. & Jun, M. P. Effect of lisocabtagene Maraleucel on HRQoL and symptom severity in relapsed\/refractory large B-cell lymphoma. Blood Adv. 5(8), 2245\u20132255. https:\/\/doi.org\/10.1182\/bloodadvances.2020003503 (2021).","journal-title":"Blood Adv."},{"issue":"8","key":"2720_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.6004\/jnccn.2020.7561","volume":"18","author":"AK Zaleta","year":"2020","unstructured":"Zaleta, A. K., Miller, M. F. & Olson, J. S. Symptom burden, perceived control, and quality of life among patients living with multiple Myeloma. J. Natl. Compr. Cancer Netw. JNCCN 18(8), 1087\u20131095. https:\/\/doi.org\/10.6004\/jnccn.2020.7561 (2020).","journal-title":"J. Natl. Compr. Cancer Network: JNCCN"},{"issue":"1","key":"2720_CR53","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1186\/s12885-018-4868-6","volume":"18","author":"J Sibeoni","year":"2018","unstructured":"Sibeoni, J., Picard, C. & Orri, M. Patients\u2019 quality of life during active cancer treatment: A qualitative study. BMC Cancer 18(1), 951. https:\/\/doi.org\/10.1186\/s12885-018-4868-6 (2018).","journal-title":"BMC cancer"},{"key":"2720_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002650","author":"K Lord","year":"2013","unstructured":"Lord, K., Ibrahim, K. & Kumar, S. Are depressive symptoms more common among British South Asian patients compared with British white patients with cancer? A cross-sectional survey. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2013-002650 (2013).","journal-title":"BMJ open."},{"issue":"8","key":"2720_CR55","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.bbmt.2018.03.027","volume":"24","author":"R Chakraborty","year":"2018","unstructured":"Chakraborty, R. et.al. Health-related quality of life after autologous stem cell transplantation for multiple Myeloma. Biol. Blood Marrow Transpl.  24(8), 1546\u20131553. https:\/\/doi.org\/10.1016\/j.bbmt.2018.03.027 (2018).","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"10","key":"2720_CR56","doi-asserted-by":"publisher","first-page":"751","DOI":"10.30773\/pi.2019.07.12","volume":"16","author":"HJ Seo","year":"2019","unstructured":"Seo, H. J., Baek, Y. G. & Cho, B. S. Anxiety and depression of the patients with hematological malignancies during hospitalization for hematopoietic stem cell Transplantation. Psychiatry Invest. 16(10), 751\u2013758. https:\/\/doi.org\/10.30773\/pi.2019.07.12 (2019).","journal-title":"Psychiatry Invest."},{"issue":"18","key":"2720_CR57","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","volume":"380","author":"N Raje","year":"2019","unstructured":"Raje, N., Berdeja, J. & Lin, Y. Anti-BCMA CAR T-Cell therapy bb2121 in relapsed or refractory multiple Myeloma. N. Engl. J. Med. 380(18), 1726\u20131737. https:\/\/doi.org\/10.1056\/NEJMoa1817226 (2019).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02720-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:00:51Z","timestamp":1747900851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02720-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17763"}}